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Conclusion. High glucose down-regulates 125I-Ang II bind-High glucose down-regulates angiotensin II binding via the PKC-
ing via the PKC-MAPK-cPLA2 signal pathway.MAPK-cPLA2 signal cascade in renal proximal tubule cells.
Background. It has been reported that renal renin-angioten-
sin system contributes to the development of diabetic nephrop-
athy. However, the mechanism of angiotensin II receptor regu-
Diabetic nephropathy, a major complication of diabe-lation in diabetic condition has not been elucidated.
tes mellitus, has been reported to be associated with theMethods. The effects of high glucose on [3H]-arachidonic
dysfunction of renal proximal tubular cells under hyper-acid (AA) release and angiotensin II (Ang II) binding and its
related signal pathway were examined in primary cultured rab- glycemic conditions [1]. Recently, it also has been re-
bit renal proximal tubule cells (PTCs). ported that renal renin-angiotensin system contributes
Results. High glucose down-regulated 125I-Ang II binding
to the development of diabetic nephropathy [2]. As an-from 12 hours and this response was sustained over 48 hours.
giotensin II (Ang II) mediates its effects by binding toThus, the treatment of 25 mmol/L glucose for 48 hours was
used for this study. High glucose-induced down-regulation of the plasma membrane Ang II receptor (ATR), accord-
125I-Ang II binding was reversed by the removal of extracellular ingly, the regulation of intrarenal ATRs in the diabetic
glucose, suggesting a role for glucose specificity. The high glu- kidney has been an area of considerable interest. Baller-
cose-induced down-regulation of 125I-Ang II binding was blocked
man, Skorecki and Brenner were the first to documentby mepacrine, AACOCF3, phospholipase A2 inhibitors, indo-
a decrease in glomerular ATR density in streptozotocinmethacin, ibuprofen, and cyclooxygenase inhibitors. Indeed,
high glucose significantly increased prostaglandin E2 synthesis. (STZ)-induced diabetic rats after three to four weeks of
In addition, the high glucose-induced AA release was blocked diabetes [3]. Similarly, Cheng, Burns and Harris showed
by PD 98059, a p44/42 mitogen-activated protein kinase (MAPK) that in the proximal tubule, where Ang II up-regulates
inhibitor. PD 98059 also prevented the down-regulation of 125I-
ATR, ATR mRNA and protein are significantly de-Ang II binding by high glucose, suggesting a role for p44/42
creased two weeks after STZ-induced diabetes [4]. TheseMAPK. Indeed, high glucose significantly increased p44/42
MAPK activity after the 15-minute time point. Protein kinase data might support the hypothesis that intrarenal Ang
C (PKC) inhibitor blocked high glucose-induced activation of II levels are elevated in diabetes, causing down-regula-
p44/42 MAPK, increase of the [3H]-AA release, and down- tion of ATRs, but the mechanism for receptor decline
regulation of 125I-Ang II binding. W-7 and KN-62 also blocked
may be more complex. However, to date the effects ofthe high glucose-induced increase of [3H]-AA release and
high glucose on ATR regulation and its related signaldown-regulation of 125I-Ang II binding. However, phospholi-
pase A2 inhibitor did not block high glucose-induced activation pathways have not been elucidated in renal proximal
of p44/42 MAPK. tubule cells, although hyperglycemia is well known to
be a primary risk factor for diabetic nephropathy.
High extracellular glucose concentrations have been
Key words: diabetic nephropathy, cell signaling, angiotensin II recep-
shown to promote the activation of protein kinase Ctor, glucose, kidney, mitogen-activated protein kinase, phospholipase
A2, protein kinase C. (PKC) due to de novo synthesis of diacylglycerol (DAG)
induced by high glucose in numerous tissues, including
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expression [7]. A recent study demonstrated that orally METHODS
administered PKC inhibitor ameliorated the develop- Isolation of rabbit renal proximal tubules and
ment of diabetic nephropathy in rats [8]. The PKC inhibi- culture conditions
tor also prevents the glucose-induced diverse cellular Rabbit renal proximal tubule cells in primary culture
response in proximal tubule cells [9, 10]. In addition, were prepared by a modification of the method of Chung
diabetes mellitus in experimental animal and human is et al [21]. The PTCs were grown in Dulbecco’s modified
associated with arachidonic acid (AA) metabolites in Eagle’s medium (DMEM)/F-12 supplemented with 15
many tissues [11, 12]. AA release occurs by the activation mmol/L HEPES buffer (pH 7.4), 20 mmol/L sodium
of phospholipase A2 (PLA2), an acyl hydrolase that spe- bicarbonate, and three growth supplements (5 g/mL
cifically cleaves the ester bond at the sn-2 position of insulin, 5 g/mL transferrin, and 5  108 mol/L hydro-
phospholipids [13]. Recent evidence suggests that activa- cortisone). Immediately prior to using the medium, the
tion of the calcium/phospholipid-dependent PKC system three growth supplements were added. Kidneys were per-
plays a key role in regulating AA release in kidney [14]. fused via the renal artery, first with phosphate-buffered
These observations are intriguing because high glucose saline (PBS), and subsequently with DMEM/F-12 con-
concentrations have been shown to increase PKC activity taining 0.5% iron oxide (wt/vol) until the kidney turned
in many tissues in vivo and in many cell types in vitro gray-black in color. Renal cortical slices were prepared
[15, 16]. Another important factor in the cascade of by cutting the renal cortex and then homogenized with
events leading to diabetic nephropathy is the p44/42 mi- four strokes of a sterile glass homogenizer. The homoge-
togen-activated protein kinase (MAPK) known as extra- nate was poured first through a 253 m and then a 83 m
cellular signal-regulated kinases (Erk) 1/2, which link mesh filter. Tubules and glomeruli on top of the 83 m
signals at the plasma membrane to nuclear events and filter were transferred into sterile DMEM/F-12 medium
are important for both stimulating and inhibiting cell containing a magnetic stirring rod, and glomeruli (con-
proliferation [17]. Awazu et al reported that p44/42 MAPK taining iron oxide) were removed with the magnetic rod.
activity increased in diabetic rat [18], and based upon The remaining proximal tubules were briefly incubated
another report it also may be regulated by other signal in DMEM/F-12 containing 60 g/mL collagenase (Class
pathways such as PKC or PLA2 [19]. Thus, we hypothe- IV) and 0.025% soybean trypsin inhibitor. The dissoci-
sized that these components may play an important role ated tubules were then washed by centrifugation, resus-
in high glucose-induced down-regulation of ATR in re- pended in DMEM/F-12 containing the three growth sup-
nal proximal tubule cells. plements, and transferred into tissue culture dishes. PTCs
The primary rabbit kidney proximal tubule cell culture were maintained at 37C, in a 5% CO2-humidified envi-
system utilized in our study retains the differentiated ronment in DMEM/F-12 medium containing the three
phenotype typical of the renal proximal tubule in vitro, supplements. The medium was changed one day after
which includes a polarized morphology [20], apical mem- plating and every two days thereafter.
brane proteins (leucine aminopeptidase and gamma glu-
125I-Ang II bindingtamyl transpeptidase), distinctive proximal tubule trans-
port systems including the Na/glucose cotransport system The Ang II binding assays were performed as de-
[21], as well as hormone responses. As observed with scribed by Becker and Harris [23] After incubating the
renal proximal tubule cells in vivo, the primary cultured PTCs with 25 mmol/L glucose for 48 hours, cells were
renal proximal tubule cells (PTCs) have a parathyroid incubated in PBS with 0.1% albumin supplemented with
hormone (PTH)-sensitive adenylate cyclase [21]. In the 125I-[Sar1, Ile8]angiotensin II (0.1 nmol/L) at 4C, followed
renal cortex not only is responsiveness to PTH observed, by three washes with ice-cold PBS with 0.1% albumin
but arginine vasopressin has a similar effect on cyclic (PBS-A). After solubilization in 0.5 N NaOH (1 mL),
AMP production due to the small number of distal tubule 900 L of each sample was transferred into scintillation
cells in this preparation [21]. However, the PTCs do not tube, and counted in a gamma counter (Wallac Wizard
respond similarly to arginine vasopressin by producing 1470, Turku, Finland). Specific binding was determined
cyclic adenosine 3,5-monophosphate (cAMP), indicat- by the equation (total binding  binding in the presence
ing that this culture system is highly purified with respect of 1 mol/L unlabeled Ang II). Internalization studies
to renal proximal tubule cells. Therefore, PTCs in hor- were performed following the final binding study wash.
monally defined, serum-free culture conditions would be A subset of cells was placed in PBS-A at 37C for 20 min-
a powerful tool for studying the effect of high glucose utes. Then, PBS-A was replaced with ice-cold acid buffer
on ATR binding [9, 22]. Therefore, in order to clarify (pH 3, 50 mmol/L acetic acid, 150 mmol/L NaCl) for five
the mechanism of ATR alteration in diabetes, we exam- minutes at 4C. The acid wash was removed and cell
ined the involvement of PKC, MAPK, and cPLA2 in lysed with 0.05 mol/L NaOH. An aliquot of lysate was
counted in a gamma counter to determine cell-associatedATR regulation in PTCs under high glucose conditions.
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radioactivity, a measure of internalized 125I-Ang II. Acid released radioactivity plus the total cell-associated radio-
activity at the end of the stimulation period).wash radioactivity was counted. The remainder of each
sample was used for protein determination by the Brad-
Prostaglandin E2 assayford method [24]. The radioactive counts in each sample
were then normalized with respect to protein. Prostaglandin E2 levels in the culture medium were mea-
sured by radioimmunoassay using a general assay proce-
Receptor recycling dure adapted from Cetta and Goetz [26]. In preliminary
studies, prostaglandin was recovered from culture me-The ATR recycling was performed as described by
Becker and Harris [23]. Cells were exposed to PBS-A or dium with extraction fluid (ethyl acetate:isopropanol:
HCl 0.05 N; 3:3:1) and the recovery rate was relativelyunlabeled Ang II (1 mol/L) at the studied surface for
20 minutes at 23C. Then cells were washed with acid buf- constant (92  3%, N  9). When PGE2 was assayed in
increasing aliquots of unextracted medium (25, 50, 100fer (pH 3, 50 mmol/L acetic acid, 150 mmol/L NaCl) for
five minutes at 23C and individual dishes were incubated L), potency estimates were parallel to a linearly trans-
formed dose response curve. Thus, the medium sampleswith PBS-A for 20 minutes and exposed to 125I-Ang II
(0.1 nmol/L) with or without unlabeled Ang II (1mol/L) were assayed directly without extraction. Each sample
was quantified using a liquid scintillation analyzer. Dupli-for 25 minutes at 23C. After washing three times with
PBS-A, cell-associated radioactivity was determined. cate hormone standards (5 to 1000 pg) were included in
each assay. The between and within assay coefficient ofPercent receptor recycling was calculated by the ratio of
specific 125I-Ang II binding at a membrane surface after variants for PGE2 were 7.3 and 6.5%, respectively.
Ang II pretreatment at that surface compared with spe-
Western blot analysis of the AT1 receptor and p44/42cific 125I-Ang II binding at the surface after incubation
MAPK phosphorylationwith buffer alone.
The effects of glucose on AT1 receptor protein and
Arachidonic acid release the p44/42 MAPK were evaluated by using AT1 receptor
antibodies and specific p44/42 MAPK monoclonal anti-[3H]-arachidonic acid release experiments were per-
formed by a modification of the method of Xing, Tao bodies for total and phospho-form. Briefly, PTCs were
incubated with 5 mmol/L glucose or 25 mmol/L glucoseand Insel [25]. Confluent monolayers of PTC cultures
were incubated for 24 hours in DMEM/F-12 medium for different times and experimental conditions. Cells
were lysed in 100 L of lysis buffer [62.5 mmol/L Tris-containing 0.5 Ci [3H]-AA/mL as well as the three
growth supplements. The monolayers were then washed HCl, pH 6.8 containing 2% SDS (wt/vol), 10% glycerol,
50 mmol/L dithiothreitol (DTT), and 0.1% bromophenolthree times with DMEM/F-12 (pH 7.4), and incubated
(at 37C) for one hour in uptake buffer containing the blue (wt/vol)] and harvested in Eppendorf tubes. The
cell lysates were sonicated for 2 seconds, heated at 95Cspecified agents at appropriate concentrations. At the
end of the incubation period, the incubation medium for five minutes, and finally centrifuged at 12,000  g
for two minutes at 4C. Small aliquots (20 L) of the su-was removed by aspiration, and transferred to ice-cold
tubes containing 100 L of 55 mmol/L egtazic acid pernatants were subjected to polyacrylamide gel (10%)
electrophoresis (PAGE) containing SDS-PAGE and(EGTA) and ethylenediaminetetraacetic acid (EDTA;
final concentration, 5 mmol/L each). The uptake buffer then transferred onto a nitrocellulose membrane (Hy-
bond C Extra; Amersham Pharmacia Biotech, Piscat-was then centrifuged at 12,000  g to eliminate cell
debris. To determine the level of radioactivity in the away, NJ, USA). The nitrocellulose sheet was blocked
with 5% nonfat dry milk in Tris-buffered saline. AT1Rsupernatant, the samples were placed in scintillation vials
containing scintillation fluid, and the radioactivity coun- protein and p44/42 MAPK were detected with specific
monoclonal antibodies for AT1R, total, or phosphory-ted using a liquid scintillation counter (Beckman Instru-
ment Inc., Fullerton, CA, USA). Cells that remained lated form (New England Biolabs, Beverly, MA, USA).
The blots were developed using a peroxidase-conjugatedattached to the plate were scraped into 1 mL of 0.1%
sodium dodecyl sulfate (SDS). The 900-L resulting cell secondary antibody, and proteins were visualized by the
enhanced chemiluminescence system (ECL; Amershamlysate was utilized for scintillation counting and the re-
maining 100 L of the cell lysate was utilized for protein Life Science, Inc.).
determinations. For each condition, the quantity of [3H]-
ChemicalsAA that had been released (determined as described
above) was first standardized with respect to protein. Dulbecco’s modified Eagle’s medium (D-MEM) and
Ham’s nutrient mixture F-12 (DMEM/F-12) and ClassSubsequently, this standardized level of released [3H]-
AA was compared by the percentage to the total level IV collagenase were purchased from Life Technologies
(Grand Island, NY, USA). d-glucose, l-glucose, mannitol,of [3H]-AA that had been incorporated into the cells
at the beginning of the incubation period (or the total A 23187, mepacrine, AACOCF3, staurosporine, nordihy-
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Fig. 2. Effect of 25 mmol/L glucose on specific 125I-Ang II membrane
binding and internalization (A), and the effect of glucose removal on
25 mmol/L glucose-induced down-regulation of 125I-Ang II binding (B).
PTCs were treated with 25 mmol/L glucose () for 48 hours and then
changed to the 5 mmol/L glucose () medium. At the indicated times,Fig. 1. Time-dependent effect of glucose on 125I-angiotensin II (125I-Ang
specific membrane 125I-Ang II binding and internalization were mea-II) binding (A). When cultures were confluent, proximal tubule cells
sured as described in the Methods section. Values are means  SE of(PTCs) were grown with 25 mmol/L glucose (0 to 72 hours) for different
three independent experiments with triplicate dishes. *P 	 0.05 vs.time periods. There was a dose-dependent effect of glucose on 125I-Ang
control, **P 	 0.05 vs. 48-hour glucose condition.II binding. (B) PTCs were treated with different doses of glucose (0 to
50 mmol/L) for 48 hours. Values are means  SE of four independent
experiments with triplicate dishes. *P 	 0.05 vs. control.
Table 1. Effects of angiotensin II (Ang II) receptor antagonists on
125I-Ang II binding
Specific 125I-Ang II bindingdroguaiaretic acid (NDGA), actinomycin D, cyclohexi-
Treatment % of control
mide, indomethacin, ibuprofen, econazole, prostaglan-
Control 100.00din E2, SB 203580, and 12-O-tetradecanoylphorbol-13- Losartan
acetate (TPA), antiserum for PGE2 were obtained from 1 nmol/L 77.585.16a
100 nmol/L 45.714.04aSigma Chemical Company (St. Louis, MO, USA). Anti-
10 mol/L 20.972.44a
body to AT1R was purchased from Santa Cruz Biotech- PD 123319
1 nmol/L 104.395.48nology (Santa Cruz, CA, USA). PD 98059 and bisindo-
100 nmol/L 88.618.88lylmaleimide I were purchased from Calbiochem (La
10 mol/L 80.495.54a
Jolla, CA, USA). [3H]-arachidonic acid, PGE2 [5, 6, 8,
Proximal tubule cells (PTCs) were pretreated with different doses of losartan
11, 12, 14, 1-3H (N)-prostaglandin E2] and 125I-[Sar1, Ile8] or PD 123319 for 30 minutes prior to the 125I-Ang II binding experiment. Values
are means  SE of three independent experiments with triplicate dishes.angiotensin II were purchased from Dupont/NEN (Bos-
a P 	 0.05 vs. control
ton, MA, USA).
RESULTSStatistical analysis
Time and dose dependency of glucose onResults were expressed as means  standard errors
125I-Ang II binding(SE). The difference between two mean values was ana-
lyzed by analysis of variance (ANOVA). The difference To determine time dependency of 125I-Ang II binding
by glucose, 25 mmol/L glucose was treated to the PTCswas considered statistically significant when P 	 0.05.
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Fig. 3. Time-dependent effects of actinomy-
cin D (AD) and cycloheximide (CHX) on high
glucose-induced down-regulation of 125I-Ang
II binding (A). Actinomycin D (108 mol/L) and
cycloheximide (106 mol/L) were pretreated at
one hour prior to the treatment of 25 mmol/L
glucose or was added at different time points
(4, 8, 12, or 24 hours) during the treatment of
25 mmol/L glucose for 48 hours, respectively.
Values are means  SE of three independent
experiments with triplicate dishes. Symbols
are: () 5 mmol/L glucose; () 25 mmol/L
glucose; ( ) AD  25 mmol/L glucose; ( )
CHX  25 mmol/L glucose; *P 	 0.05 vs.
control, **P 	 0.05 vs. 25 mmol/L glucose
alone. (B) Effect of 25 mmol/L glucose (HG)
on Ang II receptor type 1 (AT1R) protein.
Symbols are: () 5 mmol/L glucose; () 25
mmol/L glucose. Western immunoblot analy-
sis for AT1R was conducted. Band represents
50 kD of AT1R. The lower panel depicts the
data expressed as a percentage of basal value
in each fraction and is the means SE of four
experiments. *P 	 0.05 vs. each control.
for different time periods (0 to 72 hours). As shown in of 125I-Ang II was due to the decrease of both the mem-
brane and internalized 125I-bound form (Fig. 2A). UsingFigure 1A, 25 mol/L glucose over a 12-hour treatment
significantly down-regulated 125I-Ang II binding compared these data, we selected 25 mmol/L glucose for 48 hours
for the following experiments.to controls. In experiments showing the time dependency
effect on 125I-Ang II binding, there was no further down- To rule out the involvement of hyperosmolarity in high
glucose-induced down-regulation of 125I-Ang II binding,regulation of 125I-Ang II binding over 48 hours. Next, we
examined the dose dependency of glucose on 125I-Ang II mannitol or l-glucose with an equal concentration of glu-
cose (25 mmol/L) was added to the PTCs. Twenty-fivebinding. When different doses of glucose (5 to 50 mmol/L)
were used to treat the PTCs, there was a significant mmol/L mannitol and l-glucose did not affect 125I-Ang
II binding (mannitol 93.12  5.63 l-glucose; 89.11 down-regulation of Ang II binding with glucose amounts
over 15 mmol/L (Fig. 1B). However, above 25 mmol/L 6.20% 125I-Ang II binding of control; P not significant).
These results suggested that hyperosmolarity was not in-glucose there was a remarkable down-regulation of 125I-
Ang II binding. High glucose-induced down-regulation volved in the high glucose-induced down-regulation of
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cin D (108 mol/L) and cycloheximide (106 mol/L) at
one hour (that is, a 1 hour pretreatment period) prior to
the treatment of 25 mmol/L glucose blocked high glu-
cose-induced down-regulation of 125I-Ang II binding.
Figure 3B also illustrates that high glucose decreased
AT1R protein synthesis. Moreover, treatment of acti-
nomycin D and cycloheximide at different time points
(4, 8, or 12 hours) during the 25 mmol/L glucose treat-
ment for 48 hours also, in part, blocked the high glucose-
induced down-regulation of 125I-Ang II binding, although
108 mol/L actinomycin D and 106 mol/L cycloheximide
did not affect 125I-Ang II binding in our experimental
conditions.
Role of cPLA2 metabolites in high glucose-induced
down-regulation of 125I-Ang II binding
We examined whether AA plays a role in high glucose-
induced down-regulation of 125I-Ang II binding. In the
125I-Ang II binding experiments, mepacrine (106 mol/L)
or AACOCF3 (106 mol/L) was pretreated with the PTCs
prior to the treatment of 25 mmol/L glucose. As shown in
Figure 4A, mepacrine and AACOCF3 significantly blocked
25 mmol/L glucose-induced down-regulation of 125I-Ang
II binding. Figure 4B depicted that AA with different
dosages (109, 107 mol/L), but not linoleic acid (unsatu-
rated fatty acid) or myristic acid (saturated fatty acid),
down-regulated 125I-Ang II binding. These results suggest
that 25 mmol/L glucose down-regulates 125I-Ang II bind-
ing through the PLA2 signal pathway. Since AA can beFig. 4. Effect of mepacrine and AACOCF3 on high glucose-induced further metabolized via cyclooxygenase, lipoxygenase, ordown-regulation of 125I-Ang II binding (A). Symbols are: () 5 mmol/L
glucose; () 25 mmol/L glucose. PTCs were treated with mepacrine cytochrome P-450 monoxygenase, we investigated which
(106 mol/L) or AACOCF3 (106 mol/L) for 30 minutes prior to the signal pathway is involved in high glucose-induced down-
treatment of 25 mmol/L glucose. (B) Effect of arachidonic acid, linoleic
regulation of 125I-Ang II binding. Indomethacin (106acid, and myristic acid on 125I-Ang II binding. PTCs were treated with
arachidonic acid (AA), linoleic acid (LA), or myristic acid (MA) at a mol/L) and ibuprofen (104 mol/L; both of which are
different dosages of 109 and 107 mol/L. Values are means  SE of cyclooxygenase inhibitors), but not NDGA (106 mol/L,
three independent experiments with triplicate dishes. *P 	 0.05 vs.
a lipoxygenase inhibitor) or econazle (106 mol/L, a cyto-control, **P 	 0.05 vs. 25 mmol/L glucose alone.
chrome P-450 epoxygenase inhibitor), blocked high glu-
cose-induced down-regulation of 125I-Ang II binding
(Fig. 5). These results suggest that cyclooxygenase me-
125I-Ang II binding. In addition, 25 mmol/L glucose- tabolites of AA may mediate high glucose-induced down-
induced down-regulation of 125I-Ang II binding was re- regulation of 125I-Ang II binding. Indeed, 25 mmol/L glu-
versed by the removal of 25 mmol/L glucose over 24 cose increased prostaglandin E2 (PGE2) production (Fig.
hours, suggesting the specificity of glucose in the down- 5 inset; P	 0.05). PGE2 itself (107 mol/L) also exhibited
regulation of 125I-Ang II binding (Fig. 2B). down-regulation of 125I-Ang II binding (63.24  4.78%
To investigate which receptor of Ang II was down- 125I-Ang II binding of control).
regulated by high glucose, PTCs were treated with losar-
Involvement of MAPK in high glucose-inducedtan, ATR type 1 (AT1R) antagonist, and PD 123319, an
down-regulation of 125I-Ang II bindingATR type 2 antagonist, with different concentrations
ranging from 109 to 105 mol/L. Table 1 shows that losar- To investigate whether the MAPK pathway is involved
tan, but not PD 123319, inhibited 125I-Ang II binding in in high glucose-induced down-regulation of 125I-Ang II
a dose dependent manner, suggesting the AT1R down- binding, PD 98059 (p44/42 MAPK inhibitor) or SB 203580
regulation in high glucose conditions. Furthermore, we (p38 MAPK inhibitor) with different dosages (0 to 105
examined the involvement of RNA and protein synthesis mol/L) was added to the PTCs. As shown in Figure 6A,
in high glucose-induced down-regulation of 125I-Ang II PD 98059 prevented 25 mmol/L glucose-induced down-
regulation of 125I-Ang II binding in a dose dependentbinding. As shown in Figure 3A, treatment of actinomy-
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Fig. 5. Effect of cyclooxygenase inhibitor on
high glucose-induced 125I-Ang II binding. Sym-
bols are: () 5 mmol/L glucose; () 25 mmol/L
glucose. PTCs were treated with indomethacin
(106 mol/L), ibuprofen (104 mol/L; both are
cyclooxygenase inhibitors), nordihydroguaiar-
etic acid (NDGA, a lipoxygenase inhibitor, 106
mol/L), or econazole (a cytochrome P-450 ep-
oxygenase inhibitor, 106 mol/L) for 30 min-
utes prior to the treatment of 25 mmol/L glu-
cose. Inset is the result of prostaglandin E2
assay after the treatment of 25 mmol/L glucose
for 48 hours. Values are means  SE of three
independent experiments with triplicate dishes.
*P	 0.05 vs. control, **P	 0.05 vs. 25 mmol/L
glucose alone.
manner (
107 mol/L); however, SB 203580 at the same release experiment, TPA and A 23187 increased the [3H]-
dosage didn’t block it (Fig. 6B). These results suggested AA release, but staurosporine, bisindolylmaleimide I,
that p44/42 MAPK plays an important role in high glu- W-7, or KN-62 blocked the 25 mmol/L glucose-induced
cose-induced down-regulation of the 125I-Ang II binding. increase of [3H]-AA release (Fig. 10). These data demon-
Thus, we conducted an immunoblot analysis using the strated that high glucose-induced down-regulation of 125I-
p44/42 MAPK antibody. Western blot analysis of p44/42 Ang II binding was mediated by increase of [3H]-AA
MAPK showed that preincubation with 25 mmol/L glu- release through PKC activation that may be associated
cose increased p44/42 MAPK activity from the 15-minute with extracellular calcium influx. We examined whether
treatment of 25 mmol/L glucose, with a maximum effect MAPK activation by high glucose is induced via PKC-
shown at the one hour treatment (Fig. 7). In the [3H]- independent or –dependent pathway. As shown in Fig-
AA release experiment, PD 98059, but not SB 203580, ure 11, staurosporine blocked 25 mmol/L glucose-induced
also blocked the 25 mmol/L glucose-induced increase of increase of MAPK activity, whereas AACOCF3 did not
[3H]-AA release (Fig. 8). block it. These results suggest that PKC activation by
high glucose regulates MAPK activity and thus, subse-
Interaction between PKC and cPLA2 or MAPK quently, cPLA2.
in high glucose-induced down-regulation of
125I-Ang II binding
DISCUSSIONTo investigate the role of PKC in high glucose-induced
This study demonstrates that high glucose down-regu-down-regulation of 125I-Ang II binding, TPA was treated
lates 125I-Ang II binding via the PKC-MAPK-cPLA2 cas-to the PTCs alone or in combination with 25 mmol/L
cade in renal proximal tubule cells. The down-regulationglucose. Figure 9A shows that TPA alone or cotreated
of ATR in diabetic animals has been shown in severalwith 25 mmol/L glucose significantly down-regulated 125I-
reports. In streptozotocin-treated diabetic rats, there wasAng II binding compared to the control. When stauro-
a decrease of Ang II binding and Ang II mRNA in proxi-sporine (109 mol/L) or bisindolylmaleimide I (107 mol/L),
mal tubule cells [4, 27], although the mechanism waswhich are PKC inhibitors, was added to the PTCs, they
not reported. This regulation of Ang II binding by highboth significantly inhibited 25 mmol/L glucose-induced
glucose may be tissue specific, as Ang II binding in otherdown-regulation of 125I-Ang II binding. Furthermore, W-7
tissues of the diabetic rat was increased [28]. In the pres-(104 mol/L, a calmodulin antagonist) or KN-62 (106
ent study, a high glucose-induced down-regulation of 125I-mol/L, a calcium/calmodulin-dependent protein kinase II
Ang II binding of glucose was observed at the 12-hourinhibitor) blocked the 25 mmol/L glucose-induced down-
treatment time and remained down-regulated over 48regulation of 125I-Ang II binding (Fig. 9B). A 23187 also
down-regulated 125I-Ang II binding. In the [3H]-AA hours. This observation is at an earlier time than studies
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due to the different cell culture experimental conditions,
as reported in a previous study [22].
Once the Ang II binds ATR, its complex undergoes
receptor-mediated endocytosis [23]. In the present study,
the high glucose-induced down-regulation of 125I-Ang II
binding was due to a decrease of both membrane-specific
binding and the internalized form. In addition, high glu-
cose-induced down-regulation of 125I-Ang II binding, in
part, may be associated with the disruption of ATR recy-
cling, since ATR recycling was severely damaged in the
high glucose condition (control 67% vs. 25 mmol/L glu-
cose; 27% recovery-specific 125I-Ang II binding; P	 0.05).
Moreover, actinomycin D and cycloheximide blocked high
glucose-induced down-regulation of 125I-Ang II binding
and high glucose decreased the synthesis of AT1R pro-
tein, suggesting the involvement of RNA and protein syn-
thesis. This result is similar to reports from several inves-
tigators showing a decrease of AT1R mRNA and protein
level in the proximal tubule of diabetic rats [4, 23]. More-
over, based upon the results of actinomycin D and cyclo-
heximide (4 to 12 hours) after the high glucose treatment,
it is possible that mRNA stability as well as the initial
transcription and translation are involved in high glu-
cose-induced down-regulation of Ang II binding. Of in-
terest is the reversal of high glucose-induced down-regu-
lation of 125I-Ang II binding by the removal of glucose
over 24 hours, which suggests that glucose concentration
is the primary factor in the actions of high glucose. There-
fore, it is possible that the high glucose-induced down-
Fig. 6. Effects of PD 98059 (A) and SB 203580 (B) on high glucose- regulation of Ang II binding was mediated by the decrease
induced 125I-Ang II binding. Symbols are: () 5 mmol/L glucose; () of AT1R protein or/and disruption of ATR recycling.25 mmol/L glucose. PTCs were treated with PD 98059 [a p44/42 mitogen-
In STZ-induced diabetic rats [32] and mesangial cellsactivated protein kinase (MAPK) inhibitor, 0 to 105 mol/L] or SB
203580 (a p38 MAPK inhibitor, 0 to 105 mol/L) for 30 minutes prior [33], enhanced activation of PLA2 by high glucose has
to the treatment of 25 mmol/L glucose for 48 hours. Values are means been proposed to be associated with the development
 SE of three independent experiments with triplicate dishes. *P 	
of diabetic nephropathy. Our present study reveals that0.05 vs. control, **P 	 0.05 vs. 25 mmol/L glucose alone.
high glucose down-regulates 125I-Ang II binding via the
PLA2 pathway. This hypothesis is supported by the fol-
lowing results of our current study: (1) high glucose-
in the in vivo STZ-induced diabetic rat in which Ang II induced down-regulation of 125I-Ang II binding was blocked
binding decreased from 12 to 14 days [4, 27]. These down- by phospholipase A2 inhibitors; (2) AA, but not myristic
regulation effects are d-glucose–specific and it is unlikely acid and linoleic acid, also down-regulated the 125I-Ang
they were due to an osmotic effect, since the responses II binding; and (3) the high glucose-induced increase of
were not mimicked by mannitol or l-glucose. [3H]-AA release was blocked by PLA2 inhibitors. Phos-
In the present study, AT1R were the predominant pholipase A2, an acyl hydrolase that specifically cleaves
ATR in the PTCs, a result that is not in agreement with the ester bond at the sn-2 position of phospholipids [13],
a report that AT2R is the major receptor in the rabbit mediates the release of AA that by itself or its metabo-
proximal tubule [29]. In contrast, Burns, Inagami and lites can be involved in the development of diabetic ne-
Harris found that specific binding of 125I-Ang II of rabbit phropathy [34]. PLA2s are composed of a 14-kD Ca2-
renal proximal tubules was inhibited by the AT1R antag- dependent secreted PLA2, the 85-kD Ca2-dependent and
onist losartan, but not by the AT2R antagonist PD 123319 sn-2 arachidonyl-specific cytosolic PLA2 (cPLA2), and the
[30]. Several lines of evidence suggest that there was a Ca2-independent PLA2. Among these PLA2s, cPLA2 has
remarkable reduction of AT1R mRNA and protein in been shown to be responsible for the AA release medi-
the proximal tubule of diabetic rat [27]. However, Wehbi ated by diverse diseases including diabetic nephropathy.
et al reported that diabetic rat kidney exhibited a down- We previously demonstrated that high glucose induced
translocation of cPLA2 in our cell system [35], and Ha-regulation of the AT2R [31]. These differences may be
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Fig. 7. Time course of phosphorylated p44/42
mitogen-activated protein kinase (MAPK) by
high glucose. Representative autoradiographs
of time course (A). PTCs were treated at dif-
ferent time point (0 to 24 hr) with 25 mmol/L
glucose. Then, phosphorylated p44/42 MAPK
was detected as described in the Methods sec-
tion. The upper panel depicts phosphorylated
p44/42 MAPK and the lower panel depicts the
total p44/42 MAPK. The example shown is a
representative of three experiments. (B) Data
are expressed as a percentage of the basal
value of each fraction and are the means 
SE of four experiments. Symbols are: () 5
mmol/L glucose; () 25 mmol/L glucose; *P	
0.05 vs. control.
genase, a lipoxygenase, and a cytochrome P-450 depen-
dent pathway. In the present study, we observed that only
indomethacin, an inhibitor of a cyclooxygenase, blocked
the high glucose-induced down-regulation of 125I-Ang II
binding. Furthermore, correlated with this result, high
glucose increased PGE2 production and exogenous PGE2
down-regulated 125I-Ang II binding. These results are
consistent with the reports in which diabetic rat glomeru-
lar PGE2 synthesis was increased [34] and high glucose
increases PGE2 synthesis in cultured glomerular mesan-
gial cells [36]. Recently, MAPK was reported as an up-
stream regulator of AA release in many cell culture
systems [19, 33]. p44/42 MAPKs can be activated by the
serine threonine kinase Raf-1 [37], which also may beFig. 8. Effects of PD 98059, SB 203580, mepacrine, and AACOCF3 on
activated by PKC [38]. To evaluate the role of MAPKhigh glucose-induced [3H]-AA release. PTCs were treated with PD
98059 (106 mol/L), SB 203580 (106 mol/L), mepacrine (106 mol/L), in high glucose-induced down-regulation of 125I-Ang II
or AACOCF3 (106 mol/L) for 30 minutes prior to the treatment of binding, we used PD 98059, a strong p44/42 MAPK inhib-25 mmol/L glucose for one hour. Values are means  SE of three
itor, and conducted immunoblot analysis with the p44/42independent experiments with triplicate dishes. Symbols are: () 5
mmol/L glucose; () 25 mmol/L glucose; *P 	 0.05 vs. control, **P 	 MAPK antibody. The present results demonstrated that
0.05 vs. 25 mmol/L glucose alone. PD 98059 blocked high glucose-induced down-regula-
tion of 125I-Ang II binding and that high glucose peaked
p44/42 MAPK phosphorylation over 30 minutes and de-
creased it gradually in the immunoblot analysis. Thisyama et al reported that high glucose increased only
result suggests that for down-regulation of 125I-Ang IcPLA2 in mesangial cells [33]. The AA released by PTCs
binding it is also important to have an activation ofin response to high glucose treatment can be metabolized
through three different pathways, including a cyclooxy- p44/42 MAPK. Our study is the first, to our knowledge,
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Fig. 9. Effect of staurosporine, bisindolylmaleimide I, and TPA on high Fig. 10. Effect of staurosporine, bisindolylmaleimide I, and TPA onglucose-induced 125I-Ang II binding (A). PTCs were treated with stauro- high glucose-induced [3H]-AA release (A). PTCs were treated withsporine or bisindolylmaleimide I for 30 minutes prior to the treatment staurosporine or bisindolylmaleimide I for 30 min prior to the treatmentof 25 mmol/L glucose, or were incubated with 25 mmol/L glucose alone of 25 mmol/L glucose or were incubated with 25 mmol/L glucose aloneor together with TPA. (B) Effects of W-7, KN-62, and A 23187 on high or together with TPA. (B) Effects of W-7, KN-62, and A 23187 on highglucose-induced 125I-Ang II binding. Symbols are: () 5 mmol/L glucose; glucose-induced [3H]-AA release. PTCs were treated with W-7 or KN-() 25 mmol/L glucose. PTCs were treated with W-7 or KN-62 for 30 62 for 30 minutes prior to the treatment of 25 mmol/L glucose or wereminutes prior to the treatment of 25 mmol/L glucose or were incubated incubated with 25 mmol/L glucose alone or together with A 23187.with 25 mmol/L glucose alone or together with A 23187. Values are Values are means SE of three independent experiments with triplicatemeans  SE of three independent experiments with triplicate dishes. dishes. Symbols are: () 5 mmol/L glucose; () 25 mmol/L glucose;*P 	 0.05 vs. control, **P 	 0.05 vs. 25 mmol/L glucose alone. *P 	 0.05 vs. control, **P 	 0.05 vs. 25 mM glucose alone.
to show that p44/42 MAPK is involved in high glucose-
induced down-regulation of 125I-Ang II binding. Since PD mechanisms. In mesangial cells, down-regulation of PKC
abolished the stimulation of MAPK and cPLA2 [41].98059 also blocks the high glucose-induced AA release, it
is possible that p44/42 MAPK is involved in the high Haneda et al also reported that high glucose induced
activation of MAPK, which is dependent upon PKC acti-glucose-induced down-regulation of 125I-Ang II binding
via cPLA2 activation. However, p38 MAPK may not be vation in mesangial cells [42]. In contrast, in rabbit coro-
nary endothelial cells the agonist-induced increase ofinvolved in the down-regulation of 125I-Ang II binding
in the present study, although several lines of evidence cPLA2 and p42 MAPK was not dependent upon PKC
[43]. In the present study, immunoblot analysis revealshas suggested that high glucose increases the activation
of p38 MAPK in kidney [39, 40]. that p44/42 MAPK activation by high glucose is mediated
by PKC. This signal observation is similar to mesangialFurthermore, PKC also regulates activation of MAPK
and AA release in a high glucose condition. In the regula- cells in which MAPK is activated via activation of PKC
under the high glucose condition [42]. Therefore, thesetion of cPLA2, p42 MAPK has been shown to be acti-
vated by both PKC-dependent and PKC-independent observations suggest that high glucose-induced PKC acti-
Fig. 11. Effects of PKC and PLA2 inhibitor on
high glucose-induced phosphorylated p44/42
MAPK. (A) PTCs were treated with stauro-
sporine (Stauro, 109 mol/L) or AACOCF3
(106 mol/L) for 30 minutes prior to the treat-
ment of 25 mmol/L glucose (HG). Then, phos-
phorylated p44/42 MAPK was detected as de-
scribed in the Methods section. Bands migrated
to the expected 44 and 42 kD. The example
shown is representative of four experiments.
(B)The data are expressed as a percentage of
basal value in each fraction and are the
means  SE of four experiments. Symbols
are: () 5 mmol/L glucose; () 25 mmol/L
glucose; *P 	 0.05 vs. each control, **P 	
0.05 vs. 25 mmol/L glucose alone.
Fig. 12. A model for the signal pathways in-
volved in high glucose-induced down-regula-
tion of 125I-Ang II binding in the PTCs. High
glucose activates PKC, which induce activa-
tion of Ca2 channel and MAPK stimulation,
subsequently resulting in the activation of cy-
clooxygenase via PLA2. These cyclooxygenase
metabolites (ex; PGE2) may decrease the pro-
tein level for the Ang II receptor subtype 1
(ATR), and finally down-regulates 125I-Ang II
binding. Abbreviations are: AA, arachidonic
acid; Ang II, angiotensin II; COX, cyclooxy-
genase; DAG, diacylglycerol; HG, high glu-
cose; MAPK, mitogen-activated protein ki-
nase; PGE2, prostaglandin E2; PKC, protein
kinase C; PLA2, phospholipase A2. Solid line
is the proposed pathway and the dashed line is
the suspected pathway.
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